Search Result "melan-A/Mart-1"
Immunogenicity, Immunopathogenicity, and Immunotolerance in One Graph
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 10 Year: 2015 Page: 1264-1268
Author(s): Darja Kanduc
Direct Evidence on the Immune-Mediated Spontaneous Regression of Human Cancer: An Incentive for Pharmaceutical Companies to Develop a Novel Anti-Cancer Vaccine
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 2 Year: 2005 Page: 3531-3543
Author(s): F. Saleh, I. Klepacek, G. Ibrahim, H. Dashti, S. Asfar, A. Behbehani, H. Al-Sayer, A. Dashti
Melanoma Immunotherapy: Past, Present, and Future
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 2 Year: 2005 Page: 3461-3473
Author(s): F. Saleh, W. Renno, I. Klepacek, G. Ibrahim, S. Asfar, H. Dashti, P. Romero, A. Dashti, A. Behbehani
Lymphocyte Biomarkers of Clinical Responses to Adoptive Immunotherapy of Malignant Melanoma
Journal: Current Cancer Therapy Reviews
Volume: 4 Issue: 2 Year: 2008 Page: 125-129
Author(s): Nathalie Labarriere, Brigitte Dreno, Francine Jotereau
Design of Artificial Immunogens Containing Melanoma-associated T-cell Epitopes
Journal: Current Gene Therapy
Volume: 18 Issue: 6 Year: 2018 Page: 375-385
Author(s): E.A. Borobova,D.V. Antonets,E.V. Starostina,L.I. Karpenko,A.A. Ilyichev,S.I. Bazhan
Poxvirus-Based Vaccines for Cancer Immunotherapy: New Insights from Combined Cytokines/Co-Stimulatory Molecules Delivery and âUncommonâ Strains
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14 Issue: 2 Year: 2014 Page: 183-189
Author(s): Valerio Izzi,Marcin Buler,Laura Masuelli,Maria G. Giganti,Andrea Modesti,Roberto Bei
Clinical Trials Targeting Advanced Cancers by Active Immunization of T-cell Defined Tumor Antigens
Journal: Current Pharmaceutical Design
Volume: 9 Issue: 1 Year: 2003 Page: 1133-1138
Author(s): Hideyuki Ikeda
Tyrosinase Expression as a Molecular Marker for Investigating the Presence of Circulating Tumor Cells in Melanoma Patients
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 5 Year: 2010 Page: 529-538
Author(s): A. Gradilone, E. Cigna, A.M. Agliano, L. Frati
Editorial [Hot Topic: Cancer Vaccine and Immunotherapy (Executive Editor: Farid Saleh)]
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 2 Year: 2005 Page: 3459-3460
Author(s): Farid Saleh
Identification of Immunogenic MHC Class II Tyrosinase-Derived Peptides Using HLA-DR1 and HLA-DR4 Transgenic Mice
Journal: Protein & Peptide Letters
Volume: 14 Issue: 5 Year: 2007 Page: 455-460
Author(s): R. B.V. Horton, S. A.S. Laversin, S. P. Reeder, R. C. Rees, S. E.B. McArdle